Clinical trial
Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
NCT00266695 is registered in ClinicalTrials.gov with Chromaderm, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Treatment for Patients Completing Study B7A-MC-MBCM
- Lead sponsor
- Chromaderm, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- August 31, 2008
- Enrollment
- 203 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.